SENSEX NIFTY

Karvy Stock Broking

Feb 20, 2017 at 13:25 | Source: Moneycontrol.com
Centrum is bearish on GlaxoSmithKline Pharma has recommended sell rating on the stock with a target price of Rs 1340 in its research report dated February 13, 2017.
Feb 20, 2017 at 13:16 | Source: Moneycontrol.com
Centrum is bullish on Jagran Prakashan has recommended buy rating on the stock with a target price of Rs 245 in its research report dated February 13, 2017.
Feb 20, 2017 at 13:03 | Source: Moneycontrol.com
Centrum is bullish on State Bank of India has recommended buy rating on the stock with a target price of Rs 310 in its research report dated February 13, 2017.
Feb 20, 2017 at 12:56 | Source: Moneycontrol.com
Centrum is bullish on Deccan Cements has recommended buy rating on the stock with a target price of Rs 1320 in its research report dated February 10, 2017.
Feb 20, 2017 at 12:54 | Source: Moneycontrol.com
Centrum is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1110 in its research report dated February 10, 2017.
Feb 20, 2017 at 12:04 | Source: CNBC-TV18
Bharat Financial has a strong network across rural market in India and it will be a win-win if a bank like IndusInd is able to acquire it, says Digant Haria, Antique Stock Broking.
Feb 16, 2017 at 09:12 | Source: CNBC-TV18
In an interview to CNBC-TV18's Latha Venkatesh, Sonia Shenoy and Anuj Singhal, Mayuresh Joshi of Angel Broking shared his reading and outlook on the market and also gave recommendations on various stocks.
Feb 15, 2017 at 15:48 | Source: Moneycontrol.com
Most analysts noted that the Q3 results were below their estimates, but maintained their buy rating on the stock revising the target price slightly on lower side on hopes of Halol resolution, US specialty play kicking in and normalisation of India business.
Feb 15, 2017 at 15:36 | Source: Moneycontrol.com
Centrum is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1880 in its research report dated February 09, 2017.
Feb 15, 2017 at 15:30 | Source: Moneycontrol.com
Centrum is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 740 in its research report dated February 08, 2017.
Messages on Karvy Stock Broking »

amateurinve
stor

Platinum Member

2926 Followers

ITC  

Karvy Stock Broking recommended buy rating on the stock with a target price of Rs 270 per share. ITC is expected to register double digit growth in the next 2 years, by strengthening its leadership position in cigarettes segment, higher growth in FMCG business and steady performance in non

10.12 AM Dec 29th 2016

biomagic

New Member

16 Followers

Biocon  

“biosimilars is an attractive space, and with high entry barriers and limited competition, biocon clearly had the head start,” said afzaal mohammed at karvy stock broking ltd, who tracks the company. “however, the challenge for the company was to get more physicians to prescribe its products

2.21 PM Oct 7th 2016

Rocky 17

New Member

2 Followers

Sintex Industries  

opened an offline account with karvy stock broking limited but its very difficult to go to their office every time i sell shares to give the dis. is it safe to convert my trading account to an online account by giving them poa or which broker is safe whom i can give poa or should i continue

1.47 PM Sep 28th 2016

Forum Messenger

Platinum Member

376832 Followers

Currencies  

Brokerage Recommendation: Weekly Currency Report - September 26 2016 : Karvy Stock Broking

5.43 PM Sep 26th 2016

amateurinve
stor

Platinum Member

2926 Followers

index  

P.Phani Sekhar, Fund Manager of Karvy Stock Broking tells ETNow that he believes all time highs for nifty within a week from now.

11.16 PM Sep 6th 2016

Forum Messenger

Platinum Member

376832 Followers

Market Analysis - Fundamental View  

Brokerage Recommendation: Automobile Monthly Update - September 02 2016 : Karvy Stock Broking

3.42 PM Sep 2nd 2016

ltequityinv
estor

Platinum Member

65 Followers

Jyothy Laboratories  

and should be higher in coming quarters. We believe higher A&P as well as possible execution delays would limit the EBITDA margin to 15-15.5% for FY14-15 and might be revised upwards once the company consistently outperformed our EBITDA margin estimates", says Naveen Trivedi, FMCG analyst at Karvy Stock

5.35 PM Feb 8th 2013

Forum Messenger

Platinum Member

376832 Followers

Brokerage Recommendation  

Brokerage Recommendation by Karvy Stock Broking On Commodities -MMB Messenger

11.18 AM Feb 5th 2013

Forum Messenger

Platinum Member

376832 Followers

Brokerage Recommendation  

Brokerage Recommendation by Karvy Stock Broking On Commodities -MMB Messenger

10.59 AM Jan 23rd 2013

Forum Messenger

Platinum Member

376832 Followers

Brokerage Recommendation  

Brokerage Recommendation by Karvy Stock Broking On Rupee -MMB Messenger

11.44 AM Jan 21st 2013

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.